Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
| 21 | DE file number | DAKZ | 695 02 223.7 |
| 96 | EP file number | EAKZ | 95 10 2749.9 |
| 97 | EP publication number | EPN | 671387 |
| 54 | Designation/title | TI | Neue Verwendung von 1Alpha-fluor-25-hydroxy-16-en-23-yn-cholecalciferol |
| 51 | IPC main class | ICM
(ICMV) | C07C 401/00 (2006.01) |
| 22 | DE application date | DAT | Feb 27, 1995 |
| 96 | EP application date | EAT | Feb 27, 1995 |
| 43 | Date of first publication | OT | Oct 19, 1995 |
| Date of publication of grant | PET | Apr 29, 1998 |
| 71/73 | Applicant/owner | INH | F. Hoffmann-La Roche AG, 4070 Basel, CH |
| 72 | Inventor | IN | Doran, Thomas I., West Orange, New Jersey 07052, US; Shiuey, Shian-Jan, Nutley, New Jersey 07110, US; Uskokovic, Milan Radoje, Upper Montclair, New Jersey 07043, US |
| 74 | Representative | VTR | Vossius & Partner, 81675 München, DE |
| 10 | Published DE documents | DEPN | Original document:
DE000069502223T2
Searchable text:
DE000069502223T2 |
| Address for service | | Vossius & Partner Patentanwälte Rechtsanwälte, München, |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
212453
Mar 11, 1994
|
| Patent division in charge | | 43 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE |
| 43 | Date of first publication | EVT | Sep 13, 1995 |
| Date of the first transfer into DPMAregister | EREGT | Sep 27, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 20, 2013
(Show all update days)(Hide all update days)- Jan 20, 2013
- Historical data not available for this/these date(s)
- Sep 27, 2012
- Date of the first transfer into DPMAregister
|
